A novel mutation (LEU396ARG) in OPA1 is associated with a severe phenotype in a large dominant optic atrophy pedigree
Eye (Lond)
.
2018 Apr;32(4):843-845.
doi: 10.1038/eye.2017.303.
Epub 2018 Jan 19.
Authors
M J Schnieders
1
2
,
W Goar
2
3
,
M Griess
3
,
B R Roos
2
3
,
T E Scheetz
2
3
,
E M Stone
2
3
,
J H Fingert
2
3
Affiliations
1
Department of Biochemistry, Carver College of Medicine, University of Iowa, Iowa, IA, USA.
2
The Stephen A. Wynn Institute for Vision Research, University of Iowa, Iowa, IA, USA.
3
Department of Ophthalmology and Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, Iowa, IA, USA.
PMID:
29350691
PMCID:
PMC5898874
DOI:
10.1038/eye.2017.303
No abstract available
Publication types
Letter
MeSH terms
GTP Phosphohydrolases / genetics*
Genetic Predisposition to Disease
Humans
Mutation*
Optic Atrophy, Autosomal Dominant / genetics*
Pedigree
Substances
GTP Phosphohydrolases
OPA1 protein, human
Grants and funding
P30 EY025580/EY/NEI NIH HHS/United States
T32 GM008629/GM/NIGMS NIH HHS/United States